Life Sciences Software Market by Solution (Cloud-based and On-premises) and End User (Pharmaceuticals, Biotechnology, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report

High Tech, Enterprise & Consumer IT	IC_183221	Pages: NA	May 2019 \| 608 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Life science deals with the scientific study of organisms such as microorganism, human being, and animals. It includes broad range of areas of study such as biology, anatomy, health sciences, and medical sciences. The software used in life science allows a user to increase efficacy & reduce the cost of deploying valuable IT infrastructure. For instance, software as a service (SaaS) model for life science offers a pay per use model, which provides more feasibility to store patient data.

Rise in need for the improvement of operational efficiency and enhanced performance of the organization by collection & management of data efficiently by using life sciences software drive the growth of the global life sciences software market. However, high cost associated with the implementation of software impedes the market growth. Adoption of mergers and acquisitions (M&A) strategies among various life sciences companies is expected to offer a major opportunity for market expansion.

The global life sciences software market is segmented on the basis of the deployment, end user, and region. Based on deployment, the market is bifurcated into cloud-based and on-premises. The end users included in the report are pharmaceuticals, biotechnology, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The global life sciences software market is dominated by key players such as QuintilesIMS Incorporated, Autodesk Inc., PAREXEL International Corporation., Model N, Dassault Systèmes, CSC, International Business Machines Corp, SAP SE, Veeva Systems, and Medidata Solutions, Inc.

Key Benefits

The study provides an in-depth analysis of the global life sciences software market and current & future trends to elucidate the imminent investment pockets.
Information about the key drivers, restrains, and opportunities and their impact analysis on the market size is provided.
Porter’s Five Forces analysis illustrates the potency of buyers & suppliers operating in the industry.
The quantitative analysis of the global market from 2017 to 2023 is provided to determine the market potential.

Life Sciences Software Market Key Segments:

By Deployment

Cloud-based
On-premises

By End User

Pharmaceuticals
Biotechnology
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Russia
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa

Key Market Players Profiled In The Report

QuintilesIMS Incorporated
Autodesk Inc.
PAREXEL International Corporation
Model N
Dassault Systèmes
CSC
International Business Machines Corp
SAP SE
Veeva Systems
Medidata Solutions, Inc.

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 LIFE SCIENCES SOFTWARE MARKET, BY DEPLOYMENT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CLOUD-BASED

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. ON-PREMISES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 LIFE SCIENCES SOFTWARE MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. PHARMACEUTICALS

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast

5.3. BIOTECHNOLOGY

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast

5.4. OTHERS

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast

Chapter: 6 LIFE SCIENCES SOFTWARE MARKET, BY GEOGRAPHY

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Life Sciences Software Market by Deployment
6.2.5. North America Life Sciences Software Market by End User

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Life Sciences Software Market by Deployment
6.3.5. Europe Life Sciences Software Market by End User

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Life Sciences Software Market by Deployment
6.4.5. Asia-Pacific Life Sciences Software Market by End User

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA Life Sciences Software Market by Deployment
6.5.5. LAMEA Life Sciences Software Market by End User

Chapter: 7 COMPANY PROFILES

7.1. QUINTILESIMS INCORPORATED

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. AUTODESK INC

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. PAREXEL INTERNATIONAL CORPORATION.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. MODEL N

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. DASSAULT SYSTÈMES

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. CSC

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. INTERNATIONAL BUSINESS MACHINES CORP

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. SAP SE

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. VEEVA SYSTEMS

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. MEDIDATA SOLUTIONS, INC

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Life Sciences Software Market by Solution (Cloud-based and On-premises) and End User (Pharmaceuticals, Biotechnology, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025